Abstract
Several mechanisms are thought to play a role in the improvement in endothelial vasodilation produced by angiotensin-converting enzyme inhibitors. Both animal and clinical data are reviewed.
MeSH terms
-
Angiotensin-Converting Enzyme Inhibitors / pharmacology*
-
Animals
-
Bradykinin / pharmacology*
-
Coronary Disease / drug therapy*
-
Diabetic Angiopathies / drug therapy*
-
Disease Models, Animal
-
Endothelium, Vascular / drug effects
-
Endothelium, Vascular / physiopathology*
-
Humans
-
Vasodilation / drug effects
Substances
-
Angiotensin-Converting Enzyme Inhibitors
-
Bradykinin